Skip to main content
. Author manuscript; available in PMC: 2019 Jul 13.
Published in final edited form as: ACS Infect Dis. 2018 May 10;4(7):1114–1120. doi: 10.1021/acsinfecdis.8b00052

Table 2.

Activity Against ESKAPE Pathogens (MIC, μg/mL)a

E. coli (AG212) K. pneu (AG215) A. baum (AG225) E. cloacae (AG290) P. aerug (AG220)
Sisomicin 3 0.25–0.5 0.125 0.5 0.25–0.5 0.25–0.5
6′-(2-Hydroxyethyl)sisomicin 10 1 0.5 8–16 0.5–1 2–4
1-LHABA sisomicin 11 0.25–0.5 0.125 1 0.5 1
Plazomicin 4 1 0.25–0.5 2–4 0.5–1 0.5–1
Gentamicin 5 0.5–1 0.25 0.5–1 0.25 1
Tobramycin 6 1 0.25–0.5 1 0.5 0.5
Apramycin 18 4 1–2 4 2–4 4
a

All values were determined in duplicate using twofold dilution series.